中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 39 Issue 1
Jan.  2023
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2023  >  39(1): 137-141

Association of energy metabolism with serum thyroid hormone levels in patients with liver failure and their impact on prognosis

DOI: 10.3969/j.issn.1001-5256.2023.01.020
  • 1.

    Department of Infectious Disease, Linyi People's Hospital, Linyi, Shandong 276000, China

  • 2a.

    Fourth Department of Liver Disease, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China

  • 2b.

    Department of Clinical Nutrition, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China

  • 3.

    Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing 100069, China

  • 4.

    Department of Infectious Disease, Qingdao Municipal Hospital, Qingdao, Shandong 266011, China

Research funding:

Special Research Fund of Youan Medical Alliance for the Liver and Infectious Diseases (LM202011);

Beijing Municipal Natural Science Foundation (7222094)

More Information
  • Corresponding author: CHEN Yu, chybeyond1071@ccmu.edu.cn (ORCID: 0000-0003-1906-7486)
  • Received Date: 2022-06-06
  • Accepted Date: 2022-07-20
  • Published Date: 2023-01-20
    Abstract
  •   Objective  To explore the predictive value of the model for end-stage liver disease (MELD) score, energy metabolism and serum thyroid hormone levels on the severity and prognosis of patients with liver failure and their correlation.  Methods  This study collected clinicopathological data from 60 liver failure patients, e.g., end-stage liver disease (MELD) score, energy metabolism, and serum thyroid hormone levels. The χ2 test was performed to analyze the categorical variables, while the Mann-Whitney U test and independent sample t test were performed to assess the continuous variables between the two groups. Spearman correlation coefficient test was used to evaluate correlation of each index. The receiver operating characteristic (ROC) curve was used to analyze the optimal cut-off points of serum total triiodothyronine (TT3) and free triiodothyronine (FT3) levels in predicting prognosis of the patients.  Results  The rates of low TT3 and FT3 levels in liver failure patients were 78.2% and 69.1%, respectively, whereas the low TT3 rates were 95.2% and 67.6% and the low FT3 rates were 90.5% and 55.9% in survival and non-survival groups of patients, respectively (both P < 0.05). Moreover, the MELD score was significantly higher in the non-survival patients than in survival patients [26.0(21.0-29.0) vs 21.0 (19.0-24.0), Z=-3.396, P=0.001], while TT3 and FT3 levels were significantly lower in the non-survival patients than in the survival patients [0.69(0.62-0.73) vs 0.83(0.69-0.94) and 2.17(1.99-2.31) vs 2.54(2.12-2.86), respectively; Z=-2.884、-2.876, all P < 0.01]. The MELD score was negatively associated with serum TT3, FT3, and thyroid stimulating hormone (TSH) levels and the respiratory quotient (RQ) (r=-0.487、-0.329、-0.422、-0.350, all P < 0.01), whereas the RQ was associated with serum TT3 and FT3 levels (r=0.271、0.265, all P < 0.05). The optimal cutoff values in predicting the severity and survival of patients was 0.75 nmol/L and 2.37pmol/L with the sensitivity values of 67.6% and 64.7% and the specificity of 90.5% and 81.0%, respectively.  Conclusion  Abnormal thyroid hormone levels and low respiratory quotient could be used to predict the severity and prognosis of patients with liver failure.

     

    • FullText(HTML)
  • loading
    • References(17)
  • [1]
    XU MM, KONG M, YU PF, et al. Clinical course and outcome patterns of acute-on-chronic liver failure: a multicenter retrospective cohort study[J]. J Clin Transl Hepatol, 2021, 9(5): 626-634. DOI: 10.14218/JCTH.2020.00179.
    [2]
    MENG QH, HOU W, YU HW, et al. Resting energy expenditure and substrate metabolism in patients with acute-on-chronic hepatitis B liver failure[J]. J Clin Gastroenterol, 2011, 45(5): 456-461. DOI: 10.1097/MCG.0b013e31820f7f02.
    [3]
    SAM J, NGUYEN GC. Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension[J]. Liver Int, 2009, 29(9): 1396-1402. DOI: 10.1111/j.1478-3231.2009.02077.x.
    [4]
    GUNSAR F, RAIMONDO ML, JONES S, et al. Nutritional status and prognosis in cirrhotic patients[J]. Aliment Pharmacol Ther, 2006, 24(4): 563-572. DOI: 10.1111/j.1365-2036.2006.03003.x.
    [5]
    CAREGARO L, ALBERINO F, AMODIO P, et al. Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis[J]. J Hepatol, 1998, 28(1): 115-121. DOI: 10.1016/S0168-8278(98)80210-9.
    [6]
    WU Y, YOU S, ZANG H, et al. Usefulness of serum thyroid-stimulation hormone (TSH) as a prognostic indicator for acute-on-chronic liver failure[J]. Ann Hepatol, 2015, 14(2): 218-224.
    [7]
    KAYACETIN E, KISAKOL G, KAYA A. Low serum total thyroxine and free triiodothyronine in patients with hepatic encephalopathy due to non-alcoholic cirrhosis[J]. Swiss Med Wkly, 2003, 133(13-14): 210-213. DOI: 2003/13/smw-10172.
    [8]
    Organization Committee of 13th Asia-Pacific Congress of Clinical Microbiology and Infection. 13th Asia-Pacific Congress of Clinical Microbiology and Infection Consensus Guidelines for diagnosis and treatment of liver failure[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(4): 346-354. DOI: 10.1016/s1499-3872(13)60055-7.
    [9]
    MVLLER MJ, LAUTZ HU, PLOGMANN B, et al. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state[J]. Hepatology, 1992, 15(5): 782-794. DOI: 10.1002/hep.1840150507.
    [10]
    LIVESEY G, ELIA M. Estimation of energy expenditure, net carbohydrate utilization, and net fat oxidation and synthesis by indirect calorimetry: evaluation of errors with special reference to the detailed composition of fuels[J]. Am J Clin Nutr, 1988, 47(4): 608-628. DOI: 10.1093/ajcn/47.4.608.
    [11]
    YANG WB, CHEN EQ, BI HX, et al. Different models in predicting the short-term prognosis of patients with hepatitis B virus- related acute-on-chronic liver failure[J]. Ann Hepatol, 2012, 11(3): 311-319. DOI: 10.1186/1471-230X-12-44.
    [12]
    HUO TI, WU JC, LIN HC, et al. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score[J]. J Hepatol, 2005, 42(6): 826-832. DOI: 10.1016/j.jhep.2005.01.019.
    [13]
    LEE HS, CHOI GH, JOO DJ, et al. Prognostic value of model for end-stage liver disease scores in patients with fulminant hepatic failure[J]. Transplant Proc, 2013, 45(8): 2992-2994. DOI: 10.1016/j.transproceed.2013.08.036.
    [14]
    KABIR A. Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage[J]. Ann Hepatol, 2013, 12(3): 506-507. DOI: 10.3748/wjg.v19.i42.7455.
    [15]
    PENTEADO KR, COELHO JC, PAROLIN MB, et al. The influence of end- stage liver disease and liver transplantation on thyroid hormones[J]. Arq Gastroenterol, 2015, 52(2): 124-128. DOI: 10.1590/S0004-28032015000200009.
    [16]
    CASTRO I, QUISENBERRY L, CALVO RM, et al. Septic shock non- thyroidal illness syndrome causes hypothyroidism and conditions for reduced sensitivity to thyroid hormone[J]. J Mol Endocrinol, 2013, 50(2): 255-266. DOI: 10.1530/JME-12-0188.
    [17]
    MALIK R, HODGSON H. The relationship between the thyroid gland and the liver[J]. QJM, 2002, 95(9): 559-569. DOI: 10.1093/qjmed/95.9.559.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1840) PDF downloads(110) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return